Impact Factor
3.29
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.86
334 total citations
h5-index
27
h5 depth signal
Cited share
73.6%
92 of 125
Total citations
334
Citation footprint
Metric signal
2.07
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
648
Slovakia
87
Czech Republic
67
United States
30
Poland
21
Citing Fields of Research
Cancer & Development
294
Oncology
283
Noncoding RNA
265
Liver & Colon Cancer
156
Cancer, Autophagy & Apoptosis
154
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,785
Articles tracked across the journal lifetime
Indexed publication set
125
92 cited publications
Last 12 months
50
7.1 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
China
648 citing publications
Leading citing field
Cancer & Development
294 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v12n4, 1965-
v12n4, 1965-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Cancer & Development
Cancer, Autophagy & Apoptosis
Oncology
Lung Cancer
Noncoding RNA
Lymphomas
Issuing & Sponsoring Bodies
Contributor
Slovenská akadémia vied
Broad Categories
Neoplasms
Cancer, Autophagy & Apoptosis
Cancer & Development
Noncoding RNA
Lung Cancer
Digestive Disorders
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.4149/neo_2026_260622n206
Open DOI
ctDNA retesting to guide anti-EGFR therapy in later-line metastatic colorectal cancer
02
DOI 10.4149/neo_2026_260507n143
Open DOI
M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2
03
DOI 10.4149/neo_2026_260524n169
Open DOI
LAMTOR5-AS1 predicts poor prognosis and regulates glioma progression via miR-4653-5p/TCF7 axis
04
05
DOI 10.4149/neo_2026_260310n61
Open DOI
Transcriptomic analysis of vitamin D3 (cholecalciferol)-mediated attenuation of cisplatin sensitivity in gastric cancer cells in vitro
Cisplatin remains a cornerstone of chemotherapy for gastric cancer, but acquired resistance frequently limits its therapeutic efficacy. Vitamin D3/cholecalciferol (VD3) is widely used as a nutritional supplement; however, its influence o...
06
07
08
DOI 10.4149/neo_2026_260610n190
Open DOI
Neuroimmune treatment of advanced solid tumors: 3-year survival after angiotensin 1-7, pineal indoles, and cannabinoids
09
DOI 10.4149/neo_2026_260529n175
Open DOI
CRISPR/Cas9-edited organoids as a platform for tailored research of colorectal cancer
10
DOI 10.4149/neo_2026_251105n462
Open DOI
SMAP1 promotes hepatoblastoma cell proliferation by modulating the C-Kit-activated ERK/MAPK pathway
SMAP1 promotes hepatoblastoma cell proliferation by modulating the C-Kit-activated ERK/MAPK pathway
Bibliographical & Catalog Notes
Journal of the Slovenská akadémia vied.
Place of publication varies.
Called also Journal of experimental and clinical oncology.
Also issued online.
Articles in English or German, with summaries in Czech, Slovak, English, German, or Russian, 1957-68; articles in English, 1969-